In both TRAMP and PB-MYC models of PCa, we found that the proportion of epithelial cells expressing ShhnlacZ decreases greatly during tumor progression, whereas the two alternate ligands, Ihh and Dhh, are prominently expressed by tumor cells but not normal prostate luminal cells (Fig. 5; Fig. S9). The gene discussed is IHH; the disease is neoplasm.